Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy).

aroxybutynin/atomoxetine (AD109) - Apnimed

http://www.ncbi.nlm.nih.gov/pubmed/42148495

; John Cronin; Luigi Taranto-Montemurro; Patrick J Strollo; Ron Farkas; Sanjay R Patel

May 19, 2026